{"id":"8a53fbda0283","type":"article","url":"https://hartvaat.nl/2026/05/11/ehj-editorial-cleland-wereldwijde-hartfalenprevalentie-overschrijdt-600-miljoen-/","title":"EHJ-editorial Cleland: wereldwijde hartfalenprevalentie overschrijdt 600 miljoen — van gokken naar evidence","title_en":"","category":"hartfalen","category_label":"Hartfalen","professions":["apotheker","cardioloog","huisarts","internist"],"tags":["acuut-hartfalen","heart-failure-2026","hfmref","hfpef","nt-probnp","vrouwen"],"journal":"European Heart Journal","doi":"10.1093/eurheartj/ehag331","source_url":"https://doi.org/10.1093/eurheartj/ehag331","authors":["John G. F. Cleland","Mitja Lainscak","Pierpaolo Pellicori"],"significance":7,"published":"2026-05-12","source_date":"2026-05-11","image":"","kennis":["https://hartvaat.nl/kennis/hartfalen/diagnose-hartfalen-stappenplan/","https://hartvaat.nl/kennis/hartfalen/wat-is-hartfalen/"],"congress":"heart-failure-2026","summary_en":"Cleland, Lainscak, Pellicori editorial (EHJ, during HF26) revises global heart failure prevalence: historical ~60M figures reflect symptomatic HF in registries, but contemporary population-based echo screening including stage A/B, HFpEF and structural/functional abnormalities consistently finds 8–12% of older adults — implying a global population >600 million. Calls for international case-definition consensus, routine NT-proBNP + echo screening in primary care, and HF prevalence in national CV registries. Frames HF as a population-health emergency rather than a sub-specialty problem.","created":"2026-07-03T10:32:55Z","updated":"2026-07-03T18:39:33Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Editorial van John Cleland, Mitja Lainscak en Pierpaolo Pellicori (European Heart Journal, tijdens HF26): herziening van de wereldwijde hartfalenprevalentie. Historische schatting van ~60 miljoen weerspiegelt symptomatisch hartfalen in registraties. Populatie-gebaseerde echocardiografie-studies met bredere, contemporaine definities (inclusief stage A/B, HFpEF en structurele/functionele afwijkingen) identificeren consistent 8–12% van oudere volwassenen. Resulterende schatting: meer dan 600 miljoen mensen wereldwijd hebben hartfalen volgens contemporaine criteria — een orde van grootte boven de gangbare cijfers. Implicaties die de auteurs trekken: internationale consensus over case-definitions; routinematige opname van NT-proBNP en echocardiografie in primaire-zorg-screening van hoog-risico patiënten; integratie van hartfalenprevalentie in nationale cardiovasculaire registraties. Boodschap: hartfalen is een populatie-gezondheidscrisis, geen subspecialisatie-probleem — middelenallocatie moet meeschalen.","abstract_original":"Editorial reviewing recent population-level evidence on heart failure (HF) prevalence and projecting that the global HF population may now exceed 600 million when broader, contemporary definitions are applied. Historical figures of 60 million reflect symptomatic HF in registries; population-based echocardiography studies including stage A/B HF, HFpEF and structural/functional abnormalities consistently identify 8–12% of older adults, implying a far larger denominator. The authors argue for international consensus on case definitions, routine inclusion of natriuretic peptides and echocardiography in primary-care screening of high-risk patients, and integration of HF prevalence reporting into national cardiovascular registries. Implications: HF should be treated as a population-health emergency, not a sub-specialty problem, and resource allocation needs to scale accordingly."}